Qube Research & Technologies LTD Immunocore Holdings PLC Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Qube Research & Technologies LTD holds 251,819 shares of IMCR stock, worth $7.83 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
251,819
Previous 91,997
173.73%
Holding current value
$7.83 Million
Previous $5.98 Million
42.73%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding IMCR
# of Institutions
150Shares Held
39.6MCall Options Held
157KPut Options Held
135K-
Wellington Management Group LLP Boston, MA6.38MShares$198 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$151 Million2.76% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.99MShares$93.1 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.83MShares$88.1 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA1.95MShares$60.7 Million0.05% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.37B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...